1. A novel, more reliable approach to use of progression-free survival as a predictor of gain in overall survival: The Ottawa PFS Predictive Model. (April 2020) Authors: Stewart, David J.; Bossé, Dominick; Goss, Glenwood; Hilton, John F.; Jonker, Derek; Fung-Kee-Fung, Michael Journal: Critical reviews in oncology/hematology Issue: Volume 148(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies. Issue 1 (December 2016) Authors: Goss, Glenwood; Jonker, Derek; Laurie, Scott; Weberpals, Johanne; Oza, Amit; Spaans, Johanna; Porte, Charles; Dimitroulakos, Jim Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase II Study of PF‐03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207. Issue 11 (November 2016) Authors: Wheatley‐Price, Paul; Chu, Quincy; Bonomi, Maria; Seely, Jean; Gupta, Ashish; Goss, Glenwood; Hilton, John; Feld, Ronald; Lee, Christopher W.; Goffin, John R; Maksymiuk, Andrew; Murray, Nevin; Hagerman, Linda; Bradbury, Penelope A. Journal: Journal of thoracic oncology Issue: Volume 11:Issue 11(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. (April 2016) Authors: Cuffe, Sinead; Azad, Abul Kalam; Qiu, Xiaoping; Qiu, Xin; Brhane, Yonathan; Kuang, Qin; Marsh, Sharon; Savas, Sevtap; Chen, Zhuo; Cheng, Dangxiao; Leighl, Natasha B.; Goss, Glenwood; Laurie, Scott A.; Seymour, Lesley; Bradbury, Penelope A.; Shepherd, Frances A.; Tsao, Ming Sound; Chen, Bingshu E.... Journal: Cancer epidemiology Issue: Volume 41(2016:Apr.) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy. (June 2018) Authors: Bradbury, Penelope A.; Morris, Donald G.; Nicholas, Garth; Tu, Dongsheng; Tehfe, Moustapha; Goffin, John R.; Shepherd, Frances A.; Gregg, Richard W.; Rothenstein, Jeffrey; Lee, Christoper; Kuruvilla, Sara; Keith, Bruce D.; Torri, Vamsee; Blais, Normand; Hao, Desiree; Korpanty, Grzegorz J.; Goss, ... Journal: Lung cancer Issue: Volume 120(2018) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study. (July 2017) Authors: Gadgeel, Shirish; Goss, Glenwood; Soria, Jean-Charles; Felip, Enriqueta; Georgoulias, Vassilis; Lu, Shun; Cobo, Manuel; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Guclu, Salih Z.; Isla, Dolores; Morabito, Alessandro; Dupuis, Nicholas; Bühnemann, Claudia; Krämer, Nicole; Solca, Flavio; E... Journal: Lung cancer Issue: Volume 109(2017) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inpatients versus outpatients with advanced non-small cell lung cancer: Characteristics and outcomes. (2019) Authors: Gotfrit, Joanna; Jonker, Caleb; Zhang, Tinghua; Goss, Glenwood; Nicholas, Garth; Laurie, Scott; Wheatley-Price, Paul Journal: Cancer treatment and research communications Issue: Number 19(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study. Issue 12 (December 2016) Authors: Goss, Glenwood; Tsai, Chun-Ming; Shepherd, Frances A; Bazhenova, Lyudmila; Lee, Jong Seok; Chang, Gee-Chen; Crino, Lucio; Satouchi, Miyako; Chu, Quincy; Hida, Toyoaki; Han, Ji-Youn; Juan, Oscar; Dunphy, Frank; Nishio, Makoto; Kang, Jin-Hyoung; Majem, Margarita; Mann, Helen; Cantarini, Mireille; G... Journal: Lancet oncology Issue: Volume 17:Issue 12(2016:Dec.) Page Start: 1643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Osimertinib in patients with T790M mutation‐positive, advanced non–small cell lung cancer: Long‐term follow‐up from a pooled analysis of 2 phase 2 studies. Issue 6 (4th December 2018) Authors: Ahn, Myung‐Ju; Tsai, Chun‐Ming; Shepherd, Frances A.; Bazhenova, Lyudmila; Sequist, Lecia V.; Hida, Toyoaki; Yang, James C. H.; Ramalingam, Suresh S.; Mitsudomi, Tetsuya; Jänne, Pasi A.; Mann, Helen; Cantarini, Mireille; Goss, Glenwood Journal: Cancer Issue: Volume 125:Issue 6(2019) Page Start: 892 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not. (July 2016) Authors: Brule, Stephanie Y.; Al-Baimani, Khalid; Jonker, Hannah; Zhang, Tinghua; Nicholas, Garth; Goss, Glenwood; Laurie, Scott A.; Wheatley-Price, Paul Journal: Lung cancer Issue: Volume 97(2016) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗